INTERPACE BIOSCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Interpace Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Interpace Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 2, 2024 was 4.39M shares, a 1.86% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 4.39M +80.1K +1.86% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 4.38M +65K +1.51% Apr 15, 2024 10-K/A 2024-04-26
Q3 2023 4.32M +55.2K +1.3% Nov 3, 2023 10-Q 2023-11-08
Q2 2023 4.31M +67.9K +1.6% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 4.31M +85K +2.01% Mar 17, 2023 10-K 2023-03-27
Q3 2022 4.27M +92.1K +2.21% Nov 4, 2022 10-Q 2022-11-14
Q2 2022 4.25M +84.9K +2.04% Aug 5, 2022 10-Q 2022-08-15
Q1 2022 4.23M +114K +2.78% Mar 25, 2022 10-K 2022-03-31
Q3 2021 4.17M +133K +3.29% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 4.16M +125K +3.09% Aug 6, 2021 10-Q 2021-08-11
Q1 2021 4.11M +68.4K +1.69% Mar 26, 2021 10-K 2021-04-01
Q4 2020 4.06M Jan 8, 2021 10-Q 2021-01-20
Q3 2020 4.04M -34.2M -89.4% Oct 9, 2020 10-Q/A 2021-01-19
Q2 2020 4.04M -34.2M -89.4% Jun 12, 2020 10-Q/A 2021-01-19
Q1 2020 4.04M -34.1M -89.4% Apr 17, 2020 10-K/A 2021-01-19
Q3 2019 38.2M +9.6M +33.6% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 38.2M +10M +35.5% Aug 9, 2019 10-Q 2019-08-13
Q1 2019 38.1M +10.2M +36.7% Mar 15, 2019 10-K 2019-03-21
Q3 2018 28.6M +1.75M +6.5% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 28.2M +6.03M +27.2% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 27.9M +21.1M +314% Mar 12, 2018 10-K 2018-03-23
Q3 2017 26.8M +8.69M +47.8% Nov 3, 2017 10-Q 2017-11-13
Q2 2017 22.2M +4M +22% Aug 4, 2017 10-Q 2017-08-10
Q1 2017 6.72M -11.4M -63% Mar 30, 2017 10-K 2017-03-31
Q3 2016 18.2M +1.44M +8.6% Nov 10, 2016 10-Q 2016-11-17
Q2 2016 18.2M +1.45M +8.65% Aug 5, 2016 10-Q 2016-08-15
Q1 2016 18.2M +2.82M +18.4% Mar 18, 2016 10-K 2016-03-30
Q3 2015 16.7M +1.36M +8.85% Nov 6, 2015 10-Q 2015-11-12
Q2 2015 16.7M +1.35M +8.82% Aug 7, 2015 10-Q 2015-08-14
Q1 2015 15.3M -20.6K -0.13% Feb 23, 2015 10-K 2015-03-05
Q3 2014 15.4M +209K +1.38% Nov 3, 2014 10-Q 2014-11-05
Q2 2014 15.4M +171K +1.13% Aug 8, 2014 10-Q 2014-08-14
Q1 2014 15.4M +351K +2.34% Feb 28, 2014 10-K 2014-03-06
Q3 2013 15.2M +211K +1.41% Nov 10, 2013 10-Q/A 2014-09-30
Q2 2013 15.2M +244K +1.63% Aug 1, 2013 10-Q 2013-08-05
Q1 2013 15M +129K +0.86% Mar 6, 2013 10-K 2013-03-15
Q3 2012 14.9M +221K +1.5% Nov 4, 2012 10-Q 2012-11-06
Q2 2012 14.9M +223K +1.52% Aug 12, 2012 10-Q 2012-08-14
Q1 2012 14.9M Mar 6, 2012 10-K 2012-03-09
Q3 2011 14.7M Nov 6, 2011 10-Q 2011-11-10
Q2 2011 14.7M Aug 7, 2011 10-Q 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.